Cargando…
Immunoactivating Peptide P4 Augments Alveolar Macrophage Phagocytosis in Two Diverse Human Populations
New treatment strategies are urgently needed to overcome early mortality in acute bacterial infections. Previous studies have shown that administration of a novel immunoactivating peptide (P4) alongside passive immunotherapy prevents the onset of septicemia and rescues mice from lethal invasive dise...
Autores principales: | Bangert, Mathieu, Wright, Adam K., Rylance, Jamie, Kelly, Matthew J., Wright, Angela D., Carlone, George M., Sampson, Jacquelyn S., Rajam, Gowrisankar, Ades, Edwin W., Kadioglu, Aras, Gordon, Stephen B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754341/ https://www.ncbi.nlm.nih.gov/pubmed/23817378 http://dx.doi.org/10.1128/AAC.00742-13 |
Ejemplares similares
-
A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia
por: Rajam, Gowrisankar, et al.
Publicado: (2011) -
Zika Virus Causing Encephalomyelitis Associated With Immunoactivation
por: Galliez, Rafael Mello, et al.
Publicado: (2016) -
Ultrasound‐Driven Piezoelectrocatalytic Immunoactivation of Deep Tumor
por: Wu, Anbang, et al.
Publicado: (2023) -
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
por: Ling, Alexander L., et al.
Publicado: (2023) -
Using macrophage activation to augment immunotherapy of established tumours
por: Fridlender, Z G, et al.
Publicado: (2013)